Cargando…
Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
Neuromyelitis optica (NMO) is an autoimmune disease in which a specific biomarker named NMO-IgG and directed against aquaporin-4 (AQP4) has been found. A correlation between disease activity and anti-AQP4 antibody (Ab) serum concentration or complement-mediated cytotoxicity has been reported, but th...
Autores principales: | Chanson, Jean-Baptiste, Alame, Melissa, Collongues, Nicolas, Blanc, Frédéric, Fleury, Marie, Rudolf, Gabrielle, de Seze, Jérôme, Vincent, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655457/ https://www.ncbi.nlm.nih.gov/pubmed/23710199 http://dx.doi.org/10.1155/2013/146219 |
Ejemplares similares
-
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015) -
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013) -
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
por: Blanc, Frederic, et al.
Publicado: (2012) -
Detection of anti-aquaporin-4 autoantibodies in the sera of Chinese neuromyelitis optica patients★
por: Li, Miao, et al.
Publicado: (2013) -
Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)